These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 30282362)
1. Neurotoxic Effects of Aβ6-42 Peptides Mimicking Putative Products Formed by the Angiotensin Converting Enzyme. Medvedev AE; Radko SP; Yurinskaya MM; Vinokurov MG; Buneeva OA; Kopylov AT; Kozin SA; Mitkevich VA; Makarov AA J Alzheimers Dis; 2018; 66(1):263-270. PubMed ID: 30282362 [TBL] [Abstract][Full Text] [Related]
2. Conversion of Aβ43 to Aβ40 by the successive action of angiotensin-converting enzyme 2 and angiotensin-converting enzyme. Liu S; Liu J; Miura Y; Tanabe C; Maeda T; Terayama Y; Turner AJ; Zou K; Komano H J Neurosci Res; 2014 Sep; 92(9):1178-86. PubMed ID: 24823497 [TBL] [Abstract][Full Text] [Related]
3. The Down-Expression of ACE and IDE Exacerbates Exogenous Amyloid-β Neurotoxicity in CB2R-/- Mice. Wang L; Shi FX; Xu WQ; Cao Y; Li N; Li M; Wang Q; Wang JZ; Tian Q; Yu LK; Zhou XW J Alzheimers Dis; 2018; 64(3):957-971. PubMed ID: 29991137 [TBL] [Abstract][Full Text] [Related]
4. Abeta42-to-Abeta40- and angiotensin-converting activities in different domains of angiotensin-converting enzyme. Zou K; Maeda T; Watanabe A; Liu J; Liu S; Oba R; Satoh Y; Komano H; Michikawa M J Biol Chem; 2009 Nov; 284(46):31914-20. PubMed ID: 19773553 [TBL] [Abstract][Full Text] [Related]
5. A clinical dose of angiotensin-converting enzyme (ACE) inhibitor and heterozygous ACE deletion exacerbate Alzheimer's disease pathology in mice. Liu S; Ando F; Fujita Y; Liu J; Maeda T; Shen X; Kikuchi K; Matsumoto A; Yokomori M; Tanabe-Fujimura C; Shimokata H; Michikawa M; Komano H; Zou K J Biol Chem; 2019 Jun; 294(25):9760-9770. PubMed ID: 31072831 [TBL] [Abstract][Full Text] [Related]
6. Angiotensin-converting enzyme converts amyloid beta-protein 1-42 (Abeta(1-42)) to Abeta(1-40), and its inhibition enhances brain Abeta deposition. Zou K; Yamaguchi H; Akatsu H; Sakamoto T; Ko M; Mizoguchi K; Gong JS; Yu W; Yamamoto T; Kosaka K; Yanagisawa K; Michikawa M J Neurosci; 2007 Aug; 27(32):8628-35. PubMed ID: 17687040 [TBL] [Abstract][Full Text] [Related]
7. N-domain of angiotensin-converting enzyme hydrolyzes human and rat amyloid-β(1-16) peptides as arginine specific endopeptidase potentially enhancing risk of Alzheimer's disease. Kugaevskaya EV; Veselovsky AV; Indeykina MI; Solovyeva NI; Zharkova MS; Popov IA; Nikolaev EN; Mantsyzov AB; Makarov AA; Kozin SA Sci Rep; 2018 Jan; 8(1):298. PubMed ID: 29321566 [TBL] [Abstract][Full Text] [Related]
8. Emergence of Alternative Structures in Amyloid Beta 1-42 Monomeric Landscape by N-terminal Hexapeptide Amyloid Inhibitors. Chakraborty S; Das P Sci Rep; 2017 Aug; 7(1):9941. PubMed ID: 28855598 [TBL] [Abstract][Full Text] [Related]
9. Kinetic and structural characterization of amyloid-β peptide hydrolysis by human angiotensin-1-converting enzyme. Larmuth KM; Masuyer G; Douglas RG; Schwager SL; Acharya KR; Sturrock ED FEBS J; 2016 Mar; 283(6):1060-76. PubMed ID: 26748546 [TBL] [Abstract][Full Text] [Related]
10. Amyloid beta-protein is degraded by cellular angiotensin-converting enzyme (ACE) and elevated by an ACE inhibitor. Hemming ML; Selkoe DJ J Biol Chem; 2005 Nov; 280(45):37644-50. PubMed ID: 16154999 [TBL] [Abstract][Full Text] [Related]
11. Effects of Newly Synthesized Recombinant Human Amyloid-β Complexes and Poly-Amyloid-β Fibers on Cell Apoptosis and Cognitive Decline. Park S; Huh JW; Eom T; Na N; Lee Y; Kim JS; Kim SU; Shim I; Lee SR; Kim E J Microbiol Biotechnol; 2017 Nov; 27(11):2044-2051. PubMed ID: 28910862 [TBL] [Abstract][Full Text] [Related]
12. Neuroprotective Effect of SLM, a Novel Carbazole-Based Fluorophore, on SH-SY5Y Cell Model and 3xTg-AD Mouse Model of Alzheimer's Disease. Wu X; Kosaraju J; Zhou W; Tam KY ACS Chem Neurosci; 2017 Mar; 8(3):676-685. PubMed ID: 28032988 [TBL] [Abstract][Full Text] [Related]
13. Rebamipide reduces amyloid-β 1-42 (Aβ42) production and ameliorates Aβ43-lowered cell viability in cultured SH-SY5Y human neuroblastoma cells. Fukui K; Yachi K; Yoshida H; Tanji K; Matsumiya T; Hayakari R; Tsuruga K; Tanaka H; Imaizumi T Neurosci Res; 2017 Nov; 124():40-50. PubMed ID: 28587858 [TBL] [Abstract][Full Text] [Related]
14. Gnetin C, a resveratrol dimer, reduces amyloid-β 1-42 (Aβ42) production and ameliorates Aβ42-lowered cell viability in cultured SH-SY5Y human neuroblastoma cells. Seino S; Kimoto T; Yoshida H; Tanji K; Matsumiya T; Hayakari R; Seya K; Kawaguchi S; Tsuruga K; Tanaka H; Imaizumi T Biomed Res; 2018; 39(3):105-115. PubMed ID: 29899186 [TBL] [Abstract][Full Text] [Related]
15. Aβ43 is the earliest-depositing Aβ species in APP transgenic mouse brain and is converted to Aβ41 by two active domains of ACE. Zou K; Liu J; Watanabe A; Hiraga S; Liu S; Tanabe C; Maeda T; Terayama Y; Takahashi S; Michikawa M; Komano H Am J Pathol; 2013 Jun; 182(6):2322-31. PubMed ID: 23562443 [TBL] [Abstract][Full Text] [Related]
16. Estrogen protects neuroblastoma cell from amyloid-β 42 (Aβ42)-induced apoptosis via TXNIP/TRX axis and AMPK signaling. Pan Q; Guo K; Xue M; Tu Q Neurochem Int; 2020 May; 135():104685. PubMed ID: 31931042 [TBL] [Abstract][Full Text] [Related]
17. Calcium-sensing receptor antagonist (calcilytic) NPS 2143 specifically blocks the increased secretion of endogenous Aβ42 prompted by exogenous fibrillary or soluble Aβ25-35 in human cortical astrocytes and neurons-therapeutic relevance to Alzheimer's disease. Armato U; Chiarini A; Chakravarthy B; Chioffi F; Pacchiana R; Colarusso E; Whitfield JF; Dal Prà I Biochim Biophys Acta; 2013 Oct; 1832(10):1634-52. PubMed ID: 23628734 [TBL] [Abstract][Full Text] [Related]
18. Multiple cellular and molecular mechanisms are involved in human Aβ clearance by transplanted adult astrocytes. Pihlaja R; Koistinaho J; Kauppinen R; Sandholm J; Tanila H; Koistinaho M Glia; 2011 Nov; 59(11):1643-57. PubMed ID: 21826742 [TBL] [Abstract][Full Text] [Related]
19. A mimotope peptide of Aβ42 fibril-specific antibodies with Aβ42 fibrillation inhibitory activity induces anti-Aβ42 conformer antibody response by a displayed form on an M13 phage in mice. Tanaka K; Nishimura M; Yamaguchi Y; Hashiguchi S; Takiguchi S; Yamaguchi M; Tahara H; Gotanda T; Abe R; Ito Y; Sugimura K J Neuroimmunol; 2011 Jul; 236(1-2):27-38. PubMed ID: 21641049 [TBL] [Abstract][Full Text] [Related]
20. Catabolic attacks of membrane-bound angiotensin-converting enzyme on the N-terminal part of species-specific amyloid-beta peptides. Sun X; Becker M; Pankow K; Krause E; Ringling M; Beyermann M; Maul B; Walther T; Siems WE Eur J Pharmacol; 2008 Jun; 588(1):18-25. PubMed ID: 18495113 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]